Skip to content

Shattuck Labs, Inc. STTK Investing Cash Flow

Investing Cash Flow at other companies

Eli Lilly logo
Eli LillyLLY
-$3.92B-16.8%
Johnson & Johnson logo
Johnson & JohnsonJNJ
-$1.04B-250%
Amgen logo
AmgenAMGN
-$716M-60.2%
AbbVie logo
AbbVieABBV
-$574M+21.9%
Aclaris Therapeutics logo
Aclaris TherapeuticsACRS
-$30.93M-262%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$25.51M

Other financials

Income statement

See full
Revenue-
Operating income-$15.5M-8.0%
Net income-$14.8M-7.8%
EPS (diluted)-$0.13+51.9%

Balance sheet

See full
Cash & equivalents$90.4M+48.5%
Total debt$2.9M-9.5%
Total equity$95.8M+41.8%
Total assets$102.1M+32.3%

Cash flow

See full
Operating cash flow-$13.4M-11.6%
CapEx$63.0K
Free cash flow-$13.5M-12.1%

Valuation

See full
Market cap$564.45M+1,131%
Enterprise value$476.92M-4,119%
P/S564.5×+554×

Profitability

See full
Operating margin-5,266.4%-9,520pp
Net margin-4,987.4%-8,966pp
FCF margin-4,140.8%-7,144pp

Returns & leverage

See full
Return on equity-61%-8.0pp
Debt / equity0.0×
Current ratio22.1×+13.0×

Where this comes from

Reported directly by Shattuck Labs, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Shattuck Labs, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Shattuck Labs, Inc.'s investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Shattuck Labs, Inc.'s investing cash flow?
Shattuck Labs, Inc. (STTK) reported investing cash flow of $23.85M in Q1 2026.
How has Shattuck Labs, Inc.'s investing cash flow changed year-over-year?
Shattuck Labs, Inc.'s investing cash flow increased by 52.9% year-over-year, from $15.6M to $23.85M.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.